2AINH - Overview: Factor II Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor II
10AIH - Overview: Factor X Inhibitor Profile, Professional Interpretation
Interpretation of the detection and quantitation of inhibitor to coagulation factor X
11AIH - Overview: Factor XI Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to coagulation factor XI
FGAGA - Overview: Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
FNMEN - Overview: Neisseria Meningitidis IgG Vaccine Response
Neisseria Meningitidis IgG Vaccine Response
SMPB - Overview: Peripheral Blood Smear Review
Confirmation of red blood cell membrane morphology
7AINH - Overview: Factor VII Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor VII
FPHET - Overview: Anti-Phosphatidylethanolamine Panel
Anti-Phosphatidylethanolamine Panel
Interpretation of testing performed as part of a profile to evaluate laboratory evidence of disseminated intravascular coagulation
7INHT - Overview: Factor VII Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor VII testing
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....